Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday...